Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, January 06, 2010

OncoGenex - OGX-427

"We are also considering a randomized Phase 2 clinical trial investigating OGX-427 in ovarian cancer," said Scott Cormack, President and Chief Executive Officer of OncoGenex."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.